Beiwe Health � BEI-103

Based in Findland and headed by Dr. Gino Cortopassi, Beiwe Health is developing medicines that extend longevity and kill cancer cells. Currently, they claim to have two drugs in phase one trials and one drug that has completed phase one trials. Gleioblastoma BEI-103 is not recorded on clinicaltrials.gov and little information is provided on its mechanism of action.